SENSIMED Triggerfish Safety and Tolerability

Glaucoma Clinical Trial

Official title:

Evaluation of SENSIMED Triggerfish Safety and Tolerability in Glaucoma Patients and Glaucoma Suspects

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01319617
• Other study ID #: 10/05
• Status: Completed
• Phase: N/A
• First received: March 18, 2011
• Last updated: September 4, 2013
• Start date: January 2011
• Est. completion date: November 2011

Study information

• Verified date: September 2013
• Source: Sensimed AG
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Food and Drug Administration
• Study type: Interventional

Clinical Trial Summary

The purpose of this investigation is to study the safety and tolerability of SENSIMED Triggerfish, a soft contact lens-based device intended to continuously record relative changes in intraocular pressure (IOP). The investigation enrols glaucoma patients and glaucoma suspects. All subjects receive two 24-hour recording sessions with the device in an ambulatory setting and at weekly interval. The level of discomfort in the study eye after 24 hours and side effects are the main endpoints of the investigation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 41
• Est. completion date: November 2011
• Est. primary completion date: November 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Subject is able to comply with the study procedures

• Subject is 18-80 years old

• Glaucoma patient, with glaucomatous optic neuropathy based on clinical assessment of stereoscopic optic disc photographs and/or repeatable abnormal standard automated perimetry (SAP) visual fields at baseline, defined as a pattern standard deviation with P<0.05 or a glaucoma Hemifield test "outside normal limits

• Glaucoma suspect, with suspicious optic disc appearance (as determined by subjective assessment on the baseline visit) or elevated IOP (>21 mmHg) but normal and reliable SAP visual fields at baseline

• Subject has consented to be in the trial and signed informed consent is available before any study related procedures are carried out

• Visual acuity of 20/200 or better in the study eye

• Ability of subject to understand the character and individual consequences of the study

• For women with childbearing potential, adequate contraception

Exclusion Criteria:

• Subjects with contraindications for wearing contact lenses

• Severe dry eye syndrome

• Keratoconus or other corneal abnormality

• Conjunctival or intraocular inflammation

• Eye surgery prior to and throughout the study, except prior uncomplicated cataract surgery a minimum of 3 months prior to the investigation

• Full frame metal glasses during SENSIMED Triggerfish® recording

• Known hypersensitivity to silicone, plaster or ocular anesthesia

• Pregnancy and lactation

• Simultaneous participation in other clinical studies

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

• Glaucoma

Intervention

Device:
• SENSIMED Triggerfish
Soft contact lens-based device intended for continuous recording of relative changes in IOP

Locations

Country	Name	City	State
United States	University of California San Diego	San Diego	California

Sponsors (1)

Lead Sponsor	Collaborator
Sensimed AG

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Ocular Discomfort	Ocular discomfort in the study eye is reported by patients on a 100-mm visual analog scale (left end 0 mm, no discomfort; right end 100 mm, very severe discomfort) as the distance from the left end to the patient's mark after wearing the device for 24 hours at two occasions separated by one week. Values for both sessions were averaged.	After 24 hours of device wear	Yes